The Centers for Disease Control and Prevention (CDC) has issued a final investigation update regarding the multistate outbreak of Salmonella Typhimurium and Salmonella Newport infections linked to cantaloupe.
The Centers for Disease Control and Prevention (CDC) has issued a final investigation update regarding the multistate outbreak of Salmonella Typhimurium and Salmonella Newport infections linked to cantaloupe:
http://www.cdc.gov/salmonella/typhimurium-cantaloupe-08-12/index.html.
A total of 261 persons infected with the outbreak strains of Salmonella Typhimurium (228 persons) and Salmonella Newport (33 persons) were reported from 24 states; 94 ill persons were hospitalized. Three deaths were reported in Kentucky.
Collaborative investigation efforts of state, local, and federal public health and regulatory agencies indicated that cantaloupe originating from Chamberlain Farms Produce, Inc. of Owensville, Ind., was the source of this outbreak.
On Aug. 22, 2012, the Food and Drug Administration (FDA) announced a recall of cantaloupes originating from Chamberlain Farms Produce, Inc. On Oct. 3, 2012, the FDA issued a document that lists observations made by the FDA investigators during the inspection of Chamberlain Farms.
This particular outbreak appears to be over, according to the CDC; however, Salmonella is still an important cause of human illness in the United States. More information about Salmonella and steps people can take to reduce their risk for infection can be found on the CDC's Salmonella web page and the CDC Vital Signs web page at www.cdc.gov.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.